P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases

被引:30
|
作者
Mishra, Abtar [1 ]
Behura, Assirbad [1 ]
Kumar, Ashish [1 ]
Naik, Lincoln [1 ]
Swain, Ashapoorna [1 ]
Das, Mousumi [1 ]
Sarangi, Suman Sudha [1 ]
Dokania, Puja [1 ]
Dirisala, Vijaya R. [2 ]
Bhutia, Sujit K. [3 ]
Mishra, Amit [4 ]
Singh, Ramandeep [5 ]
Dhiman, Rohan [1 ]
机构
[1] Natl Inst Technol, Dept Life Sci, Lab Mycobacterial Immunol, Rourkela 769008, Odisha, India
[2] Vignans Univ, Dept Biotechnol, Guntur 522213, Andhra Pradesh, India
[3] Natl Inst Technol, Dept Life Sci, Canc & Cell Death Lab, Rourkela 769008, Odisha, India
[4] Indian Inst Technol Jodhpur, Cellular & Mol Neurobiol Unit, Jodhpur 342011, Rajasthan, India
[5] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, TB Res Lab, 3rd Milestone,Faridabad Gurugram Expressway,POB 4, Faridabad 121001, Haryana, India
关键词
P2X7; receptor; Purino-receptor; Cation channel; Calcium; NLRP3; inflammasome; P2X(7) NUCLEOTIDE RECEPTOR; NF-KAPPA-B; VIRULENT MYCOBACTERIUM-TUBERCULOSIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NLRP3 INFLAMMASOME ACTIVATION; HUMAN DENDRITIC CELLS; EXTRACELLULAR ATP; PURINERGIC RECEPTOR; HUMAN MACROPHAGES; GLUTAMATE RELEASE;
D O I
10.1016/j.ejphar.2021.174235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P2X7 receptor, a purinergic receptor family member, is abundantly expressed on many cells, including immune, muscle, bone, neuron, and glia. It acts as an ATP-activated cation channel that permits the influx of Ca2+, Na+ and efflux of K+ ions. The P2X7 receptor plays crucial roles in many physiological processes including cytokine and chemokine secretion, NLRP3 inflammasome activation, cellular growth and differentiation, locomotion, wound healing, transcription factors activation, cell death and T-lymphocyte survival. Past studies have demonstrated the up-regulation and direct association of this receptor in many pathophysiological conditions such as cancer, diabetics, arthritis, tuberculosis (TB) and inflammatory diseases. Hence, targeting this receptor is considered a worthwhile approach to lessen the afflictions associated with the disorders mentioned above by understanding the receptor architecture and downstream signalling processes. Here, in the present review, we have dissected the structural and functional aspects of the P2X7 receptor, emphasizing its role in various diseased conditions. This information will provide in-depth knowledge about the receptor and help to develop apt curative methodologies for the betterment of humanity in the coming years.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] P2X7 receptor: A potential therapeutic target for autoimmune diseases
    Cao, Fan
    Hu, Li-Qin
    Yao, Shu-Ran
    Hu, Yan
    Wang, De-Guang
    Fan, Yin-Guang
    Pan, Gui-Xia
    Tao, Sha-Sha
    Zhang, Qin
    Pan, Hai-Feng
    Wu, Guo-Cui
    AUTOIMMUNITY REVIEWS, 2019, 18 (08) : 767 - 777
  • [2] P2X7 Receptor: A Potential Therapeutic Target for Depression?
    Deussing, Jan M.
    Arzt, Eduardo
    TRENDS IN MOLECULAR MEDICINE, 2018, 24 (09) : 736 - 747
  • [3] The P2X7 receptor as a therapeutic target
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Cruz-Lopez, Olga
    Lopez-Cara, Carlota
    Preti, Delia
    Borea, Pier Andrea
    Gessi, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (05) : 647 - 661
  • [4] P2X7 Receptor as a Therapeutic Target
    De Marchi, Elena
    Orioli, Elisa
    Dal Ben, Diego
    Adinolfi, Elena
    ION CHANNELS AS THERAPEUTIC TARGETS, PT B, 2016, 104 : 39 - 79
  • [5] The P2X7 receptor is a potential therapeutic target for the treatment of Uveitis
    Tempest-Roe, S.
    Tam, F.
    Taylor, S.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [6] Purinergic P2X7 receptor as a potential therapeutic target in depression
    Qi, Wang
    Jin, Xiang
    Guan, Wei
    BIOCHEMICAL PHARMACOLOGY, 2024, 219
  • [7] P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases
    Takenouchi, Takato
    Sekiyama, Kazunari
    Sekigawa, Akio
    Fujita, Masayo
    Waragai, Masaaki
    Sugama, Shuei
    Iwamaru, Yoshifumi
    Kitani, Hiroshi
    Hashimoto, Makoto
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (02) : 91 - 96
  • [8] The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases
    Chen, Zhe
    He, Lu
    Li, Lanfang
    Chen, Linxi
    CLINICA CHIMICA ACTA, 2018, 479 : 196 - 207
  • [9] P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases
    Takato Takenouchi
    Kazunari Sekiyama
    Akio Sekigawa
    Masayo Fujita
    Masaaki Waragai
    Shuei Sugama
    Yoshifumi Iwamaru
    Hiroshi Kitani
    Makoto Hashimoto
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 91 - 96
  • [10] The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
    Qianqian Li
    Xiaodi Zhu
    Wei Song
    Xiaoxiang Peng
    Ronglan Zhao
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2731 - 2741